AI biology verification startup raises $20M seed led by Quiet Capital, ex-DeepMind researcher joins as co-founder
vqctran · x · 2026-09-17
A startup building the "verification layer" for AI-driven biology announced a $20M seed round led by Quiet Capital, with participation from Gradient, Haystack VC, Compound VC and others.
The thesis: AI is rapidly generating biological hypotheses, therapeutic candidates and experimental designs, but our ability to test them in living human biology lags far behind — existing options force a tradeoff between biological relevance and speed/cost. The company aims to build a scalable environment where models can test predictions against living human biology. Vqctran, formerly of Google DeepMind, has joined as a co-founder.
More from Venture
- AI-powered language learning platform lists for $7.5M with $137k MRR and 70% margins — marclou · 2026-09-18
- Baylor CIO: capital velocity beats multiple — three 3X funds over 18 years beat one 15X — MartinGTobias · 2026-09-17
- Stripe lays out AI payments stack: Link agent wallet, MPP, tokens and usage billing — jeff_weinstein · 2026-09-17
- An agent workflow for Reddit traffic: review 700 threads, reply to only 15, human approval before posting — mhdfaran · 2026-09-17
- Nebius GPU rate hikes and Fed hikes are connected: AI debt is pushing up yields — kevinsxu · 2026-09-17
- CNBC: OpenAI and Anthropic generate roughly 10x the revenue of all Chinese AI models combined — Polymarket · 2026-09-17